The value of natriuretic peptides for the management of heart failure: Current state of play

European Journal of Heart Failure

Volumn 3, Issue 4, 2001, Pages 395-397

  Hall, C ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE;

DIAGNOSTIC VALUE; EDITORIAL; HEART FAILURE; HUMAN; MONITORING; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; TREATMENT INDICATION;

ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; HEART FAILURE, CONGESTIVE; HUMANS; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 0034887266     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-9842(01)00151-9     Document Type: Editorial

References (6)

1. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats
2. Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomized trial
3. Guidelines for the diagnosis of heart failure. Task force of the ESC on heart failure
4. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care
5. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations
6. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: New neurohormonal predictors of left ventricular function and prognosis after myocardial infarction